Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty

• Status: Completed
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Adductor-Canal-Blockade (ACB) is superior to placebo when it comes to analgetic efficacy in high pain responders after Total Knee Arthroplasty (TKA). High pain responders are defined as patients reporting VAS > 60 during knee flexion the 1. or 2. day after surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Gentofte, Copenhagen
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• TKA within 48 hours and VAS>60 during active 45 degrees knee flexion despite conventional pain medication.

• Informed consent

• ASA 1-3

• BMI 18-40

Exclusion Criteria:

• Unable to communicate in Danish

• Allergic reactions toward drugs used in the

• Abuse of alcohol/drugs

• Unable to cooperate